Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures von Apolone, G, Joppi, R, Bertele', V, Garattini, S

Volltext

Europe’s opportunity to open up drug regulation von Garattini, Silvio, Bertele’, Vittorio

Volltext

Solicited self‐referencing undermines the credibility of researchers and journals von AVANZINI, F., BERTELE, V., PISTOTTI, V., MANNUCCI, P. M., GARATTINI, S.

Volltext

n−3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors von Roncaglioni, Maria Carla, Tombesi, Massimo, Avanzini, Fausto, Barlera, Simona, Caimi, Vittorio, Longoni, Paolo, Marzona, Irene, Milani, Valentina, Silletta, Maria Giuseppina, Tognoni, Gianni, Marchioli, Roberto

Volltext

Evidence-based clinical practice: Overview of threats to the validity of evidence and how to minimise them von Garattini, Silvio, Jakobsen, Janus C, Wetterslev, Jørn, Bertele’, Vittorio, Banzi, Rita, Rath, Ana, Neugebauer, Edmund A.M, Laville, Martine, Masson, Yvonne, Hivert, Virginie, Eikermann, Michaela, Aydin, Burc, Ngwabyt, Sandra, Martinho, Cecilia, Gerardi, Chiara, Szmigielski, Cezary A, Demotes-Mainard, Jacques, Gluud, Christian

Volltext

Provision of information on regulatory authorities' websites von Vitry, A., Lexchin, J., Sasich, L., Dupin-Spriet, T., Reed, T., Bertele, V., Garattini, S., Toop, L., Hurley, E.

Volltext

Enhancing the rational use of new medicines across European health care systems von Garattini, Silvio, Bertele', Vittorio, Godman, Brian, Haycox, Alan, Wettermark, Björn, Gustafsson, Lars L

Volltext

Policing the European pharmaceutical market's priorities von Garattini, S, Bertele', V

Volltext

Inconclusive messages from equivalence trials in thrombolysis von BERTELE, V, TORRI, V, GARATTINI, S

Volltext

Recent National and Regional Drug Reforms in Sweden: Implications for Pharmaceutical Companies in Europe von Wettermark, Björn, Godman, Brian, Andersson, Karolina, Gustafsson, Lars L., Haycox, Alan, Bertelé, Vittorio

Volltext

Multicentre clinical trials von Garattini, Silvio, Bertele, Vittorio

Volltext

Adjusting Europe's drug regulation to public health needs von Garattini, Silvio, Bertele', Vittorio

Volltext

Clinical Outcome and its Predictors in 1560 Patients with Critical Leg Ischaemia von Bertele, V, Roncaglioni, MC, Pangrazzi, J, Terzian, E, Tognoni, G

Volltext

A failed attempt at collaboration von Garattini, Silvio, Bertele´, Vittorio, Bertolini, Guido

Volltext

Rosiglitazone and the need for a new drug safety agency von Garattini, Silvio, Bertele’, Vittorio

Volltext

The scientific community should lobby to be able to apply for drug licences von Garattini, Silvio, Bertele’, Vittorio

Volltext

Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac Surgery von Salzman, E.W, Weinstein, M.J, Weintraub, R.M, Ware, J.A, Thurer, R.L, Robertson, L, Donovan, A, Gaffney, T, Bertele, V, Troll, J, Smith, M, Chute, L.E

Volltext

A matter of public interest von Garattini, Silvio, Bertele’, Vittorio

Volltext

CNS drugs approved by the centralised European procedure: true innovation or dangerous stagnation? von Barbui, Corrado, Cipriani, Andrea, Lintas, Camilla, Bertelé, Vittorio, Garattini, Silvio

Volltext

Health inequalities in Italy. Collaborative Group of the Primary Prevention Project von Roncaglioni, M C, Bertelè, V, Pangrazzi, J, Santoro, L, Tognoni, G

Volltext